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Identity 
Note: +22 is often associated with inv(16)(p13q22) or 
its equivalents; the existence of trisomy 22 solely is 
debated. 
Clinics and pathology 
Disease 
Acute non lymphocytic leukemia (ANLL). 
Phenotype/cell stem origin 
M4eo ANLL most often in cases associated with 
inv(16); M4 also, but only in 2/3 of cases, when +22 is 
apparently without inv(16); and eosinophilia may be 
missing in the latter case. 
Epidemiology 
Young age, both in cases with or without inv(16). 
Clinics 
inv(16) may be at increased CNS relapse when +22 is 
also present. 
Prognosis 
A fair prognosis is associated with +22 accompanying 
inv(16), and with +22 solely, comparable to the 
prognosis associated with inv(16). 
Cytogenetics 
Cytogenetics morphological 
+22 is a frequent anomaly additional to inv(16), but 
was not found associated with other anomalies 
recurrently found in de novo ANLL; +22 may also 
occur apparently in the absence of inv(16), but cryptic 
rearrangements of MYH11 (16p13) and CBFB (16q22) 
have been found in a number of cases; for some 
authors, +22 indicates the obligate existence of an 
inv(16); for others +22 solely is a true entity. 
Cytogenetics molecular 
Is appropriate to exclude or discover the presence of a 
hidden inv(16), inasmuch as inv(16) is associated with 
a relatively good prognosis. 
Additional anomalies 
Anomalies associated with +22 are del(7q) and/or +8, 
found in 15% of cases each; this percentage is similar 
in cases with or without inv(16). 
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